The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The SNP Genotyping And Analysis Market Projected To Become By 2030 Based On Its 2026 Valuation?
The snp genotyping and analysis market size has seen substantial growth over recent years. It is projected to expand from $18.5 billion in 2025 to $22.24 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 20.2%. Historically, this growth can be attributed to several factors, including the decreasing cost of genetic testing, the expansion of academic genomics research, an increase in disease diagnostics, significant pharmaceutical R&D investment, and advancements in microarray technologies.
The snp genotyping and analysis market is projected to experience rapid expansion over the coming years. It is set to reach $46.29 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 20.1%. This anticipated growth during the forecast timeframe is primarily driven by advancements in personalized medicine, a rise in the utilization of companion diagnostics, AI-powered genomic analytics, the broadening scope of clinical genomics, and various government genomics initiatives. Key developments expected during this period encompass the widening application of precision medicine, increasing acceptance of pharmacogenomics, greater reliance on cfdna and liquid biopsy techniques, the proliferation of high-throughput genotyping platforms, and the incorporation of artificial intelligence into genetic data analysis.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24402&type=smp
What Drivers Are Shaping The Future Growth Of The SNP Genotyping And Analysis Market?
The escalating impact of genetic diseases is anticipated to drive the expansion of the SNP genotyping and analysis market moving forward. These conditions are health irregularities stemming from DNA abnormalities in an individual, which can be passed down from one or both parents or occur from mutations during cell division. The increasing challenge posed by genetic diseases is intensifying due to enhanced public awareness and better diagnostic technologies, resulting in more diagnoses and a greater understanding of these disorders. SNP genotyping and analysis aid in addressing genetic diseases by identifying genetic variations linked to disease risk, progression, and how individuals respond to drugs, thereby enabling earlier diagnosis and individualized treatment. For example, in February 2023, the World Health Organization, an international public health body headquartered in Switzerland, estimated that congenital disorders were responsible for about 240,000 newborn fatalities worldwide within their initial 28 days of existence each year, alongside an additional 170,000 deaths among children aged 1 month to 5 years. Thus, the increasing prevalence of genetic diseases is propelling the growth of the SNP genotyping and analysis market.
What Segment Groups Are Identified Within The SNP Genotyping And Analysis Market?
The snp genotyping and analysis market covered in this report is segmented –
1) By Sample Type: Genomic DNA, Ribonucleic Acid (RNA), Cell-Free DNA (cfDNA), Plasma Samples, Whole Blood
2) By Technology: Microarrays And GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex, Sequemon MassArray Maldi-TOF, Other Technologies
3) By Application: Disease Diagnostics, Pharmacogenomics, Precision Medicine, Forensic Science, Agriculture And Livestock
4) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical And Biotechnological Companies, Diagnostic Laboratories, Academic And Government Institutions
Subsegments:
1) By Genomic DNA: Whole Genome Sequencing (WGS), Targeted Sequencing, Microarrays
2) By Ribonucleic Acid (RNA): RNA-Seq, Expression Profiling, Microarrays
3) By Cell-Free DNA (cfDNA): Liquid Biopsy, Non-Invasive Prenatal Testing (NIPT), Oncology Research
4) By Plasma Samples: Circulating Tumor DNA (ctDNA), Liquid Biopsy Applications, Diagnostics
5) By Whole Blood: DNA Extraction And Analysis, Blood-Based Genomic Studies, Genotyping And Molecular Diagnostics
What Trends Are Advancing Progress In The SNP Genotyping And Analysis Market?
Leading companies active in the SNP genotyping and analysis market are concentrating on developing technologically advanced solutions, such as agricultural large-scale low-pass whole genome sequencing, to tackle significant issues in molecular breeding genotyping of agricultural diploid species. Agricultural whole genome sequencing is the process of deciphering the complete genetic material of crops or livestock to enhance traits like yield, disease resistance, and environmental adaptability. As an example, in June 2024, MGI Tech, a China-based biotechnology company, introduced a highly efficient complete workflow solution for agricultural large-scale low-pass whole genome sequencing (low-pass WGS). This solution includes an automated full-process product portfolio covering DNA extraction, library preparation, sequencing, and SNP & InDel calling, specifically engineered for molecular breeding genotyping of agricultural diploid species. It features advanced automation platforms and employs MGI’s DNBSEQ-T7 and DNBSEQ-G400 sequencers to achieve ultra-high throughput and flexibility. The workflow also incorporates pig reference panels and data analysis software to streamline genotyping without the necessity of custom database creation.
Which Companies Hold Significant Positions In The SNP Genotyping And Analysis Market?
Major companies operating in the snp genotyping and analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Eurofins Genomics Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Life Sciences Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., Azenta Life Sciences Inc., LGC Limited, Invitae Corporation, Oxford Nanopore Technologies Limited, Standard BioTools Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Sophia Genetics SA, Genedata AG, Genotypic Technology Private Limited, PREMIER Biosoft International
Read the full snp genotyping and analysis market report here:
https://www.thebusinessresearchcompany.com/report/snp-genotyping-and-analysis-global-market-report
Which Geographic Regions Are Influencing Demand In The SNP Genotyping And Analysis Market?
North America was the largest region in the SNP genotyping and analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the snp genotyping and analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored SNP Genotyping And Analysis Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24402&type=smp
Browse Through More Reports Similar to the Global SNP Genotyping And Analysis Market 2026, By The Business Research Company
Single Nucleotide Polymorphism Snp Genotyping Market Report 2026
Genotyping Market Report 2026
https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report
Genotyping Assay Market Report 2026
https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model